Form 8-K - Current report:
SEC Accession No. 0001104659-24-106406
Filing Date
2024-10-07
Accepted
2024-10-07 06:07:04
Documents
13
Period of Report
2024-10-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425371d1_8k.htm   iXBRL 8-K 30097
  Complete submission text file 0001104659-24-106406.txt   204952

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA seel-20241001.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE seel-20241001_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE seel-20241001_pre.xml EX-101.PRE 22359
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2425371d1_8k_htm.xml XML 3676
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 241356046
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)